Mitchell A. Jackson, M.D., is a board-certified ophthalmologist specializing in cataract and refractive surgery. He received his medical degree from Chicago Medical School, completed his internship at Columbus Hospital and his Ophthalmology residency at University of Chicago Hospitals. Currently, Dr. Jackson is the Founder/Medical Director of Jacksoneye and is also a clinical assistant at the University of Chicago Hospitals.
Dr. Jackson has extensive experience in laser vision correction, performing over 30,000 LASIK procedures since its FDA approval for use in 1995. Confident in laser vision correction, Dr. Jackson experienced the LASIK procedure as a patient in May 2000 and is able to explain the procedure from a patient’s perspective.
Dr. Jackson is involved in many phase 2, 3 and 4 FDA clinical trials such as the the surachoroidal stent for glaucoma treatment at the time of cataract surgery, the One-Piece Tecnis Multifocal Lens Implant, collagen cross-linking for keratoconus and post-Lasik ectasia, and Dry Eye Treatments including the Tear Science device for lid margin disease. He is also the Medical Monitor on various other ophthalmic studies such as intracameral pharmaceuticals in cataract surgery, and serves as the US Ambassador for the Laser ACE procedure for presbyopia being performed internationally.
“I don’t mind taking on the challenging cases and doing whatever it takes to get people to see.”
– Dr. Jackson
Dr. Jackson is a member and is actively involved in the following professional societies: